We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleSelective BRAFV600E inhibitor PLX4720, requires TRAIL assistance to overcome oncogenic PIK3CA resistance.AuthorsOikonomou E; Koc M; Sourkova V; Andera L; Pintzas APublicationPloS one, 2011, Vol 6, Issue 6, pe21632ISSN1932-6203Publication typearticleDOI10.1371/journal.pone.0021632